164 related articles for article (PubMed ID: 3067982)
1. Metastasis of unknown origin.
Haskell CM; Cochran AJ; Barsky SH; Steckel RJ
Curr Probl Cancer; 1988; 12(1):5-58. PubMed ID: 3067982
[TBL] [Abstract][Full Text] [Related]
2. Metastasis of unknown origin.
Perchalski JE; Hall KL; Dewar MA
Prim Care; 1992 Dec; 19(4):747-57. PubMed ID: 1465485
[TBL] [Abstract][Full Text] [Related]
3. Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary tumor site.
Hainsworth JD; Greco FA
Semin Oncol; 1993 Jun; 20(3):279-86. PubMed ID: 8503024
[TBL] [Abstract][Full Text] [Related]
4. [Diagnosis and treatment of unknown primary tumors].
Dodion P; De Valeriola D
Bull Cancer; 1989; 76(9):939-46. PubMed ID: 2695183
[TBL] [Abstract][Full Text] [Related]
5. Metastatic adenocarcinoma of unknown primary origin.
Hammar SP
Hum Pathol; 1998 Dec; 29(12):1393-402. PubMed ID: 9865824
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and management of metastatic neoplasms with unknown primary.
Bochtler T; Löffler H; Krämer A
Semin Diagn Pathol; 2018 May; 35(3):199-206. PubMed ID: 29203116
[TBL] [Abstract][Full Text] [Related]
7. The value of postmortem examination in cases of metastasis of unknown origin-20-year retrospective data from a tertiary care center.
Al-Brahim N; Ross C; Carter B; Chorneyko K
Ann Diagn Pathol; 2005 Apr; 9(2):77-80. PubMed ID: 15806513
[TBL] [Abstract][Full Text] [Related]
8. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
9. Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs).
Pisacane A; Cascardi E; Berrino E; Polidori A; Sarotto I; Casorzo L; Panero M; Boccaccio C; Verginelli F; Benvenuti S; Dellino M; Comoglio P; Montemurro F; Geuna E; Marchiò C; Sapino A
Virchows Arch; 2023 Mar; 482(3):463-475. PubMed ID: 36346458
[TBL] [Abstract][Full Text] [Related]
10. Poorly differentiated neuroendocrine carcinoma of unknown primary site. A newly recognized clinicopathologic entity.
Hainsworth JD; Johnson DH; Greco FA
Ann Intern Med; 1988 Sep; 109(5):364-71. PubMed ID: 2841895
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and therapeutic management of cancer of an unknown primary.
Pavlidis N; Briasoulis E; Hainsworth J; Greco FA
Eur J Cancer; 2003 Sep; 39(14):1990-2005. PubMed ID: 12957453
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin-based combination chemotherapy in the treatment of poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary site: results of a 12-year experience.
Hainsworth JD; Johnson DH; Greco FA
J Clin Oncol; 1992 Jun; 10(6):912-22. PubMed ID: 1375284
[TBL] [Abstract][Full Text] [Related]
13. Carcinoma of unknown primary (CUP).
Pavlidis N; Fizazi K
Crit Rev Oncol Hematol; 2009 Mar; 69(3):271-8. PubMed ID: 18977667
[TBL] [Abstract][Full Text] [Related]
14. Metastasis of unknown origin: the role of fine-needle aspiration cytology.
Reyes CV; Thompson KS; Jensen JD; Choudhury AM
Diagn Cytopathol; 1998 May; 18(5):319-22. PubMed ID: 9582563
[TBL] [Abstract][Full Text] [Related]
15. Malignancies of undetermined primary origin.
Bitran JD; Ultmann JE
Dis Mon; 1992 Apr; 38(4):213-60. PubMed ID: 1547698
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical staining for thyroid transcription factor-1: a helpful aid in discerning primary site of tumor origin in patients with brain metastases.
Srodon M; Westra WH
Hum Pathol; 2002 Jun; 33(6):642-5. PubMed ID: 12152164
[TBL] [Abstract][Full Text] [Related]
17. Metastatic cancer with unknown primary.
Greenberg BR; Lawrence HJ
Med Clin North Am; 1988 Sep; 72(5):1055-65. PubMed ID: 2842554
[TBL] [Abstract][Full Text] [Related]
18. Managing carcinomas of unknown primary site.
Hainsworth JD; Greco FA
Oncology (Williston Park); 1988 Jul; 2(7):43-9, 52-4. PubMed ID: 3275052
[TBL] [Abstract][Full Text] [Related]
19. Management of patients with cancer of unknown primary site.
Hainsworth JD; Greco FA
Oncology (Williston Park); 2000 Apr; 14(4):563-74; discussion 574-6, 578-9. PubMed ID: 10826316
[TBL] [Abstract][Full Text] [Related]
20. [Metastases of unknown origin--principles of diagnosis and treatment].
Petrović D; Muzikravić L; Jovanović D
Med Pregl; 2007; 60(1-2):29-36. PubMed ID: 17853708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
